Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
USRE37516 | CEPHALON | Acetamide derivative having defined particle size |
Oct, 2014
(9 years ago) | |
USRE37516 (Pediatric) | CEPHALON | Acetamide derivative having defined particle size |
Apr, 2015
(9 years ago) | |
US7297346 | CEPHALON | Pharmaceutical formulations of modafinil |
Nov, 2023
(4 months ago) | |
US7297346 (Pediatric) | CEPHALON | Pharmaceutical formulations of modafinil |
May, 2024
(a month from now) |
Market Authorisation Date: 24 December, 1998
Treatment: Improved wakefulness in patients with excessive daytime sleepiness associated with narcolepsy
Dosage: TABLET;ORAL